61 related articles for article (PubMed ID: 22074845)
1. Antinuclear and antiphospholipid antibodies in patients with multiple sclerosis.
Szmyrka-Kaczmarek M; Pokryszko-Dragan A; Pawlik B; Gruszka E; Korman L; Podemski R; Wiland P; Szechinski J
Lupus; 2012 Apr; 21(4):412-20. PubMed ID: 22074845
[TBL] [Abstract][Full Text] [Related]
2. Clinical interpretation of antinuclear antibody tests in systemic rheumatic diseases.
Satoh M; Vázquez-Del Mercado M; Chan EK
Mod Rheumatol; 2009; 19(3):219-28. PubMed ID: 19277826
[TBL] [Abstract][Full Text] [Related]
3. Relevance of antinuclear antibody in diagnosis and characteristics of multiple sclerosis.
Koshorek J; Hu C; Wang Y; Grkovski R; Lin D; Fitzgerald K; Newsome SD; Mowry EM
Mult Scler Relat Disord; 2024 May; 87():105639. PubMed ID: 38704876
[TBL] [Abstract][Full Text] [Related]
4. Antibodies target microvessels in neuromyelitis optica and multiple sclerosis patients.
Long Y; Gao C; Qiu W; Hu X; Peng F; Lu Z
Neurol Res; 2013 Nov; 35(9):922-9. PubMed ID: 23845827
[TBL] [Abstract][Full Text] [Related]
5. [Antinuclear antibodies in multiple sclerosis].
Antigüedad A; Ruiz J; Mendibe MM; Zarranz JJ
Neurologia; 1997; 12(6):245-8. PubMed ID: 9303591
[TBL] [Abstract][Full Text] [Related]
6. Should we systematically test patients with clinically isolated syndrome for auto-antibodies?
Negrotto L; Tur C; Tintoré M; Arrambide G; Sastre-Garriga J; Río J; Comabella M; Nos C; Galán I; Vidal-Jordana A; Simon E; Castilló J; Palavra F; Mitjana R; Auger C; Rovira À; Montalban X
Mult Scler; 2015 Dec; 21(14):1802-10. PubMed ID: 25778697
[TBL] [Abstract][Full Text] [Related]
7. Serum antinuclear antibody may be associated with less severe disease activity in neuromyelitis optica.
Masuda H; Mori M; Uzawa A; Muto M; Uchida T; Kuwabara S
Eur J Neurol; 2016 Feb; 23(2):276-81. PubMed ID: 25903772
[TBL] [Abstract][Full Text] [Related]
8. Central nervous system-specific antinuclear antibodies in patients with multiple sclerosis.
Fujii T; Yamasaki R; Miyachi Y; Nagata S; Maimaitijiang G; Nakamura Y; Shinoda K; Matsushita T; Isobe N; Kira JI
J Neurol Sci; 2020 Feb; 409():116619. PubMed ID: 31835211
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and visual prognosis of very late-onset neuromyelitis optica spectrum disorder-related optic neuritis.
Yang Q; Lai C; Meng C; Chang Q; Wei N; Wang J
Neurol Sci; 2024 May; 45(5):2191-2197. PubMed ID: 37982973
[TBL] [Abstract][Full Text] [Related]
10. CNS demyelinating events in primary Sjögren's syndrome: A single-center case series on the clinical phenotype.
Afzali AM; Moog P; Kalluri SR; Hofauer B; Knopf A; Kirschke JS; Hemmer B; Berthele A
Front Neurol; 2023; 14():1128315. PubMed ID: 36873454
[TBL] [Abstract][Full Text] [Related]
11. Differentiating central nervous system demyelinating disorders: The role of clinical, laboratory, imaging characteristics and peripheral blood type I interferon activity.
Karathanasis DK; Rapti A; Nezos A; Skarlis C; Kilidireas C; Mavragani CP; Evangelopoulos ME
Front Pharmacol; 2022; 13():898049. PubMed ID: 36034800
[No Abstract] [Full Text] [Related]
12. Serum antinuclear antibodies associate with worse prognosis in AQP4-positive neuromyelitis optica spectrum disorder.
Fan R; Zhang Y; Xu Y; Tong J; Chen Z; Gu M; Fan W; Chen Y; Peng F; Jiang Y
Brain Behav; 2021 Jan; 11(1):e01865. PubMed ID: 33319460
[TBL] [Abstract][Full Text] [Related]
13. Elevated Concentrations of Soluble Fas and FasL in Multiple Sclerosis Patients with Antinuclear Antibodies.
Sremec J; Tomasović S; Tomić Sremec N; Šućur A; Košćak Lukač J; Bačić Baronica K; Grčević D; Kovačić N
J Clin Med; 2020 Nov; 9(12):. PubMed ID: 33256256
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of diagnostic criteria and red flags of myelin oligodendrocyte glycoprotein encephalomyelitis in a clinical routine cohort.
Veselaj K; Kamber N; Briner M; Friedli C; Diem L; Guse K; Miclea A; Wiest R; Wagner F; Grabe H; Abegg M; Horn MP; Bigi S; Chan A; Hoepner R; Salmen A
CNS Neurosci Ther; 2021 Apr; 27(4):426-438. PubMed ID: 33047894
[TBL] [Abstract][Full Text] [Related]
15. Atypical Pediatric Demyelinating Diseases of the Central Nervous System.
Troxell RM; Christy A
Curr Neurol Neurosci Rep; 2019 Nov; 19(12):95. PubMed ID: 31773416
[TBL] [Abstract][Full Text] [Related]
16. The MRZ-Reaction and Specific Autoantibody Detection for Differentiation of ANA-Positive Multiple Sclerosis From Rheumatic Diseases With Cerebral Involvement.
Venhoff N; Thiel J; Rizzi M; Venhoff A; Rauer S; Endres D; Hentze C; Staniek J; Huzly D; Voll RE; Salzer U; Hottenrott T
Front Immunol; 2019; 10():514. PubMed ID: 30941143
[No Abstract] [Full Text] [Related]
17. Antiphospholipid Antibodies Overlapping in Isolated Neurological Syndrome and Multiple Sclerosis: Neurobiological Insights and Diagnostic Challenges.
D'Angelo C; Franch O; Fernández-Paredes L; Oreja-Guevara C; Núñez-Beltrán M; Comins-Boo A; Reale M; Sánchez-Ramón S
Front Cell Neurosci; 2019; 13():107. PubMed ID: 30941020
[TBL] [Abstract][Full Text] [Related]
18. Comparisons of presentations and outcomes of neuromyelitis optica patients with and without Sjögren's syndrome.
Zhong YH; Zhong ZG; Zhou Z; Ma ZY; Qiu MY; Peng FH; Zhang WX
Neurol Sci; 2017 Feb; 38(2):271-277. PubMed ID: 27817092
[TBL] [Abstract][Full Text] [Related]
19. Peripheral VH4+ plasmablasts demonstrate autoreactive B cell expansion toward brain antigens in early multiple sclerosis patients.
Rivas JR; Ireland SJ; Chkheidze R; Rounds WH; Lim J; Johnson J; Ramirez DM; Ligocki AJ; Chen D; Guzman AA; Woodhall M; Wilson PC; Meffre E; White C; Greenberg BM; Waters P; Cowell LG; Stowe AM; Monson NL
Acta Neuropathol; 2017 Jan; 133(1):43-60. PubMed ID: 27730299
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
